Related Experiment Videos

OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2

H H Song1, W Shi, J Filmus

  • 1Department of Medical Biophysics, University of Toronto, Toronto, Ontario M4N 3M5, Canada.

Insights

OCI-5, a glypican-3 homolog, does not interact with insulin-like growth factor-2 (IGF-2). However, OCI-5 binds to fibroblast growth factor-2 (FGF-2) via its heparan sulfate chains.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • OCI-5 is the rat homologue of glypican-3, a proteoglycan implicated in Simpson-Golabi-Behmel overgrowth syndrome.
  • Glypican-3 has been suggested to interact with insulin-like growth factor-2 (IGF-2), potentially regulating its activity.

Purpose of the Study:

  • To investigate the interaction between OCI-5 and IGF-2.
  • To determine if OCI-5 interacts with other growth factors, such as FGF-2.

Main Methods:

  • Transfection of OCI-5 into two distinct cell lines.
  • Co-immunoprecipitation assays to detect protein interactions.
  • Inhibition studies using heparin and heparitinase to identify the role of heparan sulfate chains.

Main Results:

  • No detectable interaction was observed between OCI-5 and IGF-2 in transfected cells.
  • OCI-5 was found to interact with fibroblast growth factor-2 (FGF-2).
  • This OCI-5 and FGF-2 interaction was confirmed to be mediated by the heparan sulfate chains of OCI-5.

Conclusions:

  • The rat glypican-3 homologue, OCI-5, does not interact with IGF-2.
  • OCI-5 interacts with FGF-2 through its heparan sulfate chains, similar to glypican-1.
  • These findings provide new insights into the differential binding properties of glypicans and their roles in growth factor regulation.

Related Concept Videos